Shares of pharmaceutical giant Cipla rose on March 15 after the company announced plans to sell its 51.18% majority stake in its Ugandan subsidiary Cipla...
India’s benchmark index fell more than 1% on January 25, with the Nifty index closing below 17,900, amid a sell-off across sectors, especially power, oil...
Cipla’s wholly owned UK arm has contracted in Ethris worth β¬15 million, a universal leader in transporting mRNAs directly to the respiratory system with administration...
India’s stock benchmark fell on Friday, tracking pessimism in global markets, as data from the world’s largest economy offered little reason to ease the Fed’s...
India’s stock market benchmark opened lower on Tuesday, the second day of its most significant drop in more than two months, weighed down by weakness...
India’s stock market benchmark fell on Thursday, pulling back from a four-month high on weakness in IT, healthcare and oil and gas stocks. Globally, investors...